NCLEX Archer Pharmacology Practice Test

Managing an abdominal aortic aneurysm often involves controlling factors such as blood pressure and heart rate to reduce the risk of rupture. Atenolol, a selective beta-1 adrenergic antagonist, is commonly prescribed for this purpose. By lowering heart rate and reducing myocardial contractility, atenolol effectively decreases the strain on the aortic wall, thereby minimizing the risk of aneurysm growth and rupture. The use of medications like naproxen, which is a non-steroidal anti-inflammatory drug (NSAID), does not target the cardiovascular parameters that are critical in managing an abdominal aortic aneurysm. Similarly, digoxin, primarily used to treat heart failure and certain types of arrhythmias, does not have a direct role in managing aneurysms. Prednisone, a corticosteroid, is effective for inflammatory conditions but does not address the hemodynamic issues associated with an abdominal aortic aneurysm. Thus, atenolol plays a key role by addressing the underlying cardiac factors that contribute to the risk associated with this condition.